UK Markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6520+0.0520 (+8.67%)
As of 02:06PM EST. Market open.
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.68
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.3500
52-week low 30.5000
50-day moving average 30.8376
200-day moving average 31.4564

Share statistics

Avg vol (3-month) 32.18M
Avg vol (10-day) 3800.84k
Shares outstanding 532.62M
Implied shares outstanding 6N/A
Float 841.45M
% held by insiders 11.11%
% held by institutions 111.56%
Shares short (14 Nov 2021) 4799.59k
Short ratio (14 Nov 2021) 40.35
Short % of float (14 Nov 2021) 41.66%
Short % of shares outstanding (14 Nov 2021) 41.65%
Shares short (prior month 14 Oct 2021) 4907.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 307 May 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 May 2019

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-67.76%
Return on equity (ttm)-124.61%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -24.61M
Net income avi to common (ttm)-27.23M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.34M
Total cash per share (mrq)0.44
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.70
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-19.82M
Levered free cash flow (ttm)-8.67M